https://orcid.org/0000-0002-5313-5967
References
- Ruan KH . Advance in understanding the biosynthesis of prostacyclin and thromboxane A2 in the endoplasmic reticulum membrane via the cyclooxygenase pathway. Mini Rev. Med. Chem.4(6), 639–647 (2004).
- Ruan KH , SoSP , CervantesV , WuH , WijayaC , JentzenRR. An active triple-catalytic hybrid enzyme engineered by linking cyclo-oxygenase isoform-1 to prostacyclin synthase that can constantly biosynthesize prostacyclin, the vascular protector. FEBS J.275(23), 5820–5829 (2008).
- Ruan KH , DengH , SoSP. Engineering of a protein with cyclooxygenase and prostacyclin synthase activities that converts arachidonic acid to prostacyclin. Biochemistry45(47), 14003–14011 (2006).
- Ruan DT , TangN , AkasakaH , LuR , RuanKH. Engineering ‘Enzymelink’ for screening lead compounds to inhibit mPGES-1 while maintaining prostacyclin synthase activity. Future Med. Chem.13(13), 1091–1103 (2021).
- Takeuchi K , TanakaA , OhnoR , YokotaA. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. J. Physiol. Pharmacol.54(Suppl. 4), 165–182 (2003).
- Bindu S , MazumderS , BandyopadhyayU. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem. Pharmacol.180, doi: 10.1016/j.bcp.2020.114147 (2020).
- Nakatani Y , HokonoharaY , KakutaS , SudoK , IwakuraY , KudoI. Knockout mice lacking cPGES/p23, a constitutively expressed PGE2 synthetic enzyme, are peri-natally lethal. Biochem. Biophys. Res. Commun.362(2), 387–392 (2007).
- Zhang Y , SchneiderA , RaoRet al. Genomic structure and genitourinary expression of mouse cytosolic prostaglandin E(2) synthase gene. Biochim. Biophys. Acta1634(1–2), 15–23 (2003).
- Nakatani Y , HokonoharaY , TajimaY , KudoI , HaraS. Involvement of the constitutive prostaglandin E synthase cPGES/p23 in expression of an initial prostaglandin E2 inactivating enzyme, 15-PGDH. Prostaglandins Other Lipid Mediat.94(3–4), 112–117 (2011).
- Hansen K , VarvasK , JärvingI , SamelN. Novel membrane-associated prostaglandin E synthase-2 from crustacean arthropods. Comp. Biochem. Physiol. B Biochem. Mol. Biol.174, 45–52 (2014).
- Kotsos D , TziomalosK. Microsomal prostaglandin e synthase-1 and -2: emerging targets in non-alcoholic fatty liver disease. Int. J. Mol. Sci.24(3), 3049 (2023).
- Nitz I , FisherE , GrallertHet al. Association of prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism with type 2 diabetes in two German study populations. J. Clin. Endocrinol. Metab.92(8), 3183–3188 (2007).
- Lindner I , HelwigU , RubinDet al. Prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism and parameters of the metabolic syndrome. Mol. Nutr. Food Res.51(12), 1447–1451 (2007).
- Zhong D , WanZ , CaiJet al. mPGES-2 blockade antagonizes β-cell senescence to ameliorate diabetes by acting on NR4A1. Nat. Metab.4(2), 269–283 (2022).
- Sun Y , JiaZ , YangGet al. mPGES-2 deletion remarkably enhances liver injury in streptozotocin-treated mice via induction of GLUT2. J. Hepatol.61(6), 1328–1336 (2014).
- Wang C , ChenY , WangYet al. Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1. J. Exp. Clin. Cancer Res.38(1), 371 (2019).
- Hyodo T , ItoY , HosonoKet al. The role of mPGES-1 in promoting granulation tissue angiogenesis through regulatory T-cell accumulation. In Vivo36(5), 2061–2073 (2022).
- Rappl P , RösserS , MaulPet al. Inhibition of mPGES-1 attenuates efficient resolution of acute inflammation by enhancing CX3CL1 expression. Cell Death Dis.12(2), 135 (2021).
- Raucci F , SavianoA , CasilloGMet al. IL-17-induced inflammation modulates the mPGES-1/PPAR-γ pathway in monocytes/macrophages. Br. J. Pharmacol.179(9), 1857–1873 (2022).